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Phytol  protected  mice  against  pilocarpine-induced  seizures.
Phytol reduces  mortality  rate  caused  by  seizures.
Phytol exhibits  anticonvulsant  activity  in  pilocarpine  model.
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a  b  s  t  r  a  c  t
The  present  study  investigated  the  effects  of phytol  in  pilocarpine-induced  seizures.  The  latency  for  devel-
opment  of convulsions  and  mortality  rate  was  recorded  in this  model  using  mice.  The  results  revealed
that  phytol  (25,  50 and  75 mg/kg,  i.p.) increased  latency  to  ﬁrst  seizure  and  decreased  percentage  of  these
seizures.  Moreover,  phytol  also protected  the  animals  against  status  epilepticus  induced  by pilocarpine,
and  decreased  the  mortality  rate.  Mice  treated  with  pilocarpine  (n =  24)  presented  100%  of  mortality
during  the  ﬁrst  hour  of  observation.  In  turn,  phytol-pretreated  animals  within  30  min  before  the  admin-
istration  of  pilocarpine  (400  mg/kg)  remained  alive  during  the  ﬁrst hour  of  observation.  On  the other  hand,
6–8  h after  administration  of  pilocarpine  it was observed  that  10 (41.66%),  8  (33.33%)  and  4  (16.66%)  ani-ilocarpine
eizures
mals  died  (respectively).  Thus,  the  pretreatment  with  phytol  was  able  to  block  mortality  rate  during  the
ﬁrst  hour  in  acute  phase  of seizures,  and  signiﬁcantly  reduced  this  rate  in a dose-dependent  manner
(p  <  0.05),  suggesting  an  anticonvulsant  effect.  In  addition,  none  of the  phytol  effects  was  blocked  by
pre-treatment  with  ﬂumazenil,  an  antagonist  of benzodiazepine  receptors.  In conclusion,  phytol  exhibits
anticonvulsant  activity  by modulating  of neurotransmitter  systems,  but  further  investigations  are  in
progress  to conﬁrm  this  pharmacological  property.
© 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.pilepsy is a common chronic neurological disorder that affects
–2% of the world population [22]. Although seizures in two-thirds
f the patients can be successfully controlled with anticonvulsant
edications, the remaining one-third remains refractory to med-
cal therapy [21]. This fact has stimulated a considerable research
or new antiepileptic drugs with higher safety and efﬁcacy than the
urrently available anticonvulsants. In this regard, medicinal plants
ave been an important source in the development of new drugs
ith anticonvulsant activity [7].
Interestingly, in the last years, a large number of evidences
as demonstrated that natural products from folk therapies
ave contributed signiﬁcantly in the discovery of modern drugs.
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Open access under the Elsevier OA license.Additionally, numerous herbal medicines are active on central ner-
vous system (CNS), and they have at least a hypothetical potential to
affect chronic conditions that do not respond well to conventional
treatments [6–8].
Development and introduction of new drugs with greater safety
and efﬁcacy is essential to enhance treatment of epilepsy. The
search for less toxic alternatives resulted in decreased use of com-
binations of medicinal plants and the introduction of synthetic
substances. This notion is supported by previous studies showing
that some monoterpenes present in several essential oils, such as
thymoquinone [18], citronellol [26], ,-epoxy-carvone [11] and
isopulegol [25], possess anticonvulsant activity.
Among the diterpenes, phytol is chemically deﬁned as 3,7,11,15-
tetramethylhexadec-2-en-1-ol. Phytol is an aromatic ingredient
used in many fragrance compounds. It may  be found in cosmet-
ics as well as in non-cosmetic products [19]. Phytol is a member
of branched-chain unsaturated alcohols whose common charac-


















































s16 J.P.  Costa et al. / Neuroscie
wenty and one double bond carbon atoms can be observed in their
hemical structure [3].
Phytol is a constituent of chlorophyll [1,2]. Studies showed that
onsiderable amounts of phytanic acid accumulated in lipids of
iver, kidney, muscle and urine of a patient with Refsum’s disease
20,28]. However, the effects of this diterpene on central nervous
ystem have not yet been studied. Thus, the objective of this study
as to evaluate the anticonvulsant activity of phytol and charac-
erize its mechanism of action on pilocarpine-induced seizures.
For  this study, the drugs ﬂumazenil, phytol, pilocarpine
ydrochloride, polyoxyethylene-sorbitan monolated (Tween 80)
ere purchased from Sigma Chemical Co., St. Louis, MO (USA) and
iazepam (DZP) from Cristália (Brazil). The dosage of all drugs was
xpressed as milligrams per kilogram of body weight.
Adult male Swiss mice (25–30 g; 2 months old) were maintained
n a temperature-controlled room (26 ± 1 ◦C) with a 12-h light/dark
ycle, with food and water ad libitum (Nutrilabor, Campinas, Brazil).
ll experiments were approved by the Ethics Committee on Ani-
al Experiments at Federal University of Piauí (CEEA/UFPI #
13/11). Mice were divided into ﬁve random groups (n = 24). The
rst group represented control group and received placebo vehi-
le (0.05% Tween 80 dissolved in 0.9% saline); the second group
as treated with pilocarpine hydrochloride (400 mg/kg, i.p.). The
emaining groups received an injection of phytol (PHY) at doses
f 25, 50 and 75 mg/kg emulsiﬁed in vehicle. Thirty minutes after
rug administration, mice were treated with pilocarpine (i.p.) at
 dose of 400 mg/kg. Then, they were observed for 1 h to mon-
tor latency to the ﬁrst seizure (tonic–clonic seizures with or
ithout rearing), the latency to status epilepticus (intermittent
eizures for up to 30 min), occurrences of wild running, clonuses,
onus, clonic–tonic seizures (with or without rearing), the num-
er of animals that seized, and death after P400 administration
13,15].
Previous work has shown that convulsions and deaths occur-
ing always within 1–24 h following postinjection. It was decided to
bserve animals for 1 h whereas pilocarpine-induced convulsions
tart within 30–60 min  and deaths within 1–24 h after pilocarpine
njection. Survivors were sacriﬁced by decapitation and their brains
ere dissected and put in ice to remove hippocampus for determi-
ations of neurochemical alterations in future studies. The P400
roup was constituted by those rats that presented seizures; SE for
ver 30 min  and did not die within 1 h.
After this experimental procedure, possible participation of the
enzodiazepine site of GABAA receptors of GABAergic receptors
n modulating the effect of phytol on anticonvulsant activity was
valuated. For this purpose, FLU, a selective GABAA-BZD recep-
or antagonist [4,5,12], was administered in two  groups of mice,
5 min  before either diazepam or PHY treatments. Thirty minutes
fter the last treatment each animal was injected with pilocarpine.
he latency to the ﬁrst seizure, the number of animals showing
able 1
ffects of phytol and cholinergic drugs on pilocarpine-induced seizures and lethality in a
Groups Latency to ﬁrst seizures (min) % Seizures Latency
P400 7.90 ± 1.68 100 14.95 ±
PHY  25 + P400 19.10 ± 3.83a 41.66d 29.20 ±
PHY  50 + P400 24.25 ± 5.17a,b 33.33d,e 34.10 ±
PHY  75 + P400 27.50 ± 6.36a,b,c 16.66d,e, f 37.50 ±
esults for latency to ﬁrst seizure and latency to status epilepticus were expressed as me
eizures and percentage survival were expressed as percentages of the number of animal
a p < 0.05 as compared with P400 group.
b p < 0.05 as compared with PHY 25 + P400 group.
c p < 0.05 as compared with PHY 50 + P400 group (ANOVA and t-Student–Newman–Keu
d p < 0.05 as compared with P400 group.
e p < 0.05 as compared with PHY 25 + P400.
f p < 0.05 as compared with PHY 50 + P400 group (2-test).tters 523 (2012) 115– 118
convulsions, latency to installation of the status epilepticus, and
number of animals that died were the parameters recorded.
In  another series of experiments, 30 min  after treatment
with vehicle or 75 mg/kg of PHY or 5 mg/kg of diazepam or
25 mg/kg of ﬂumazenil (FLU), mice (n = 12) received pilocarpine
(i.p., 400 mg/kg) they were and observed for 1 h to detect the latency
to the ﬁrst seizure, the latency to status epilepticus, the occurrence
of wild running, clonuses, tonus, clonic–tonic seizures, the number
of animals that seized and number of animals that died after pilo-
carpine administration. Diazepam and FLU were used as reference
drugs.
Since the results of latency to ﬁrst seizure and status
epilepticus show a parametric distribution, they were com-
pared by one-way analysis of variance (ANOVA) followed by
t-Student–Newman–Keuls. The number of animals that seized and
those that survived were calculated as percentages, and compared
with a nonparametric test (2). In both situations, statistical sig-
niﬁcance was considered when p < 0.05. The statistical analyses
were performed with the software GraphPad Prism, Version 5.00
for Windows, GraphPad Software (San Diego, CA, USA).The results
show that, in general, intraperitoneal administration of phytol did
not produce toxic effects on animals’ behavior, whereas it was  not
seen clinical or behavioral signs toxicity during 30 min observation
period prior to treatment with pilocarpine. After treatment with
doses of 25, 50 and 75 mg/kg, no changes were detected in response
to the touch and ambulation.
After  3–5 min  following pilocarpine administration, all ani-
mals showed peripheral cholinergic signs (miosis, piloerection,
chromodacriorrhea, diarrhea and masticatory). They also showed
stereotyped movements (continuous snifﬁng, paw licking and rear-
ing) followed by motor limbic seizures (p < 0.001). The convulsive
process persisted and built up to a status epilepticus in all mice,
leading to death (p < 0.001) (Table 1). All animals pre-treated with
phytol in this experiment were observed for 1 h after pilocarpine
injection and manifested alterations in behavior, such as peripheral
cholinergic signs, tremors, staring spells, facial automatisms, wet
dog shakes and rearing.
Pre-administration of phytol caused a dose-dependent protec-
tion against pilocarpine-induced seizures and status epilepticus
and reduced mortality rate induced by pilocarpine (p < 0.05,
Table 1). Similar outcomes were also observed with diazepam
(5 mg/kg) used as reference drug (Table 2).
Pilocarpine induced the ﬁrst seizure at 7.90 ± 1.68 min  and
status epilepticus at 14.95 ± 1.57 min. As detailed in Table 1, pre-
treatment with phytol caused a dose-dependent delay of latency to
the ﬁrst seizure when compared to the pilocarpine group. In addi-
tion, phytol caused increasing in latency to installation of status
epilepticus.
With 75 mg/kg 83.34% of the animals were protected against
seizures; occurrence of status epilepticus was  reduced by 83.34%,
dult mice.
 to status epilepticus (min) % Survival Number of animals/group
 1.57 0 24
 3.75a 58.34d 24
 3.46a,b 66.67d,e 24
 4.50a,b,c 83.34d,e, f 24
an ± S.E.M. of the number of experiments shown in the table. Result for percentage
s from each experimental group.
ls as post hoc test).
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Table 2
Effect of pretreatment with phytol and GABAergic drugs on pilocarpine-induced seizures and lethality in adult mice.
Groups Latency to ﬁrst seizures (min) % Seizures Latency to status epilepticus (min) % Survival Number of animals/group
P400 7.90 ± 1.68 100 14.95 ± 1.57 0 24
DZP  5 0 0 0 100 24
DZP  5 + P400 15.40 ± 3.50a 25d 23.33 ± 0.58a 75c 24
PHY  75 + P400 27.50 ± 6.36a 16.66c 37.50 ± 4.50a 83.33c 24
FLU  25 0 0 0 100 24
FLU  25 + P400 7.92 ± 0.57 100 14.91 ± 0.57 0 24
FLU  25 + DZP 5 + P400 7.89 ± 0.59b 100d 14.88 ± 0.43b 0d 24
FLU  25 + PHY 75 + P400 27.42 ± 1.94 16.66 37.45 ± 0.85 83.33 24
Results for latency to ﬁrst seizure and latency to status epilepticus were expressed as mean ± S.E.M of the number of experiments shown in the table. Result for percentage
seizures and percentage survival were expressed as percentages of the number of animals from each experimental group.
a p < 0.05 as compared with P400 group.
b p < 0.05 as compared with DZP 5 + P400 group (ANOVA and t-Student–Newman–Keuls as post hoc test).
c p < 0.05 as compared with P400 group.









































tatency of status epileptic increased up to 151%, and 83.34% of ani-
als maintained alive in comparison with control group (Table 1).
ince this dose of phytol showed a stronger effect (p < 0.001), it was
elected for follow-up studies. In our experiments, Phytol-treated
ice showed no death during the ﬁrst hour of observation. Deaths
ave occurred in between 6 and 8 h in the groups treated with phy-
ol after administration of pilocarpine, suggesting that phytol can
roduce a neuroprotective effects.
The anticonvulsant effects of phytol are more potent than those
hown by diazepam (Table 2). Nevertheless, to determine whether
he anticonvulsant effects of phytol are exerted via GABAergic
ystems, phytol-treated mice were subjected to a co-treatment
ith ﬂumazenil, a benzodiazepine receptor antagonist. However,
umazenil did not revert the anticonvulsant effect of phytol, but
locked the diazepam action (Table 2). None of the animals that
eceived injections of 0.05% Tween dissolved in 0.9% saline (con-
rol), ﬂumazenil, diazepam and phytol alone presented seizure
ctivity.
In this study, we have used the model of epilepsy induced by
 high dose (400 mg/kg) of pilocarpine since our research group
as standardized this model. In previous studies, we  have already
ocumented data of the acute phase of this model, which facili-
ates interpretation of results with natural compounds during this
odel’s phase [9,10].
The  pilocarpine model is a useful experimental proce-
ure to investigate the development of neuropathology of
eizures [8,14]. In this model, the initial precipitating injury
s characterized by a prolonged status epilepticus (SE), which
auses neuronal loss, gliosis and vacuolar degeneration in rat
ippocampus [23].
Although  the mechanism of pilocarpine-induced seizures
nd SE is not completely understood, it is known that it
epends on muscarinic activation and alterations in acetyl-
holinesterase activity in rat hippocampus [16]. Following the
oxicity induced by an initial cholinergic phase, a distinct non-
holinergic phase occurs with an excessive production of free
adicals [29].
As  a consequence of neuronal connection disruption between
rain regions, pilocarpine-induced seizures produce dysfunctions
n many brain regions [14]. The behavioral changes during seizures
n rats have been widely reported. These behaviors are replicable
nd reversed by acute administration of antiepileptic and antioxi-
ants compounds [24,29].In the present work, the anticonvulsant effects of phytol was
erformed. Phytol was ﬁrst evaluated in a behavioral study that
ives a good indication of protection to mortality and status epilep-
icus induce by pilocarpine.The phytol is an acyclic terpenoid, which is part of the chloro-
phyll molecule [27]. Phytol derivatives may  activate nuclear
hormone receptors and inﬂuence gene expression and cell differen-
tiation [17]. These pharmacological effects attributed to phytol can
be responsible for controlling neuronal function, inﬂuencing neu-
rotransmitter systems and modulating the release and/or synthesis
of inhibitory neurotransmitters related to the seizure process.
Surprisingly, results demonstrate that phytol inhibited the
action of pilocarpine, and protected mice against death induced
by seizures. These discoveries make phytol a good candidate for
drugs designed to produce neuroprotection in response to seizures.
The current development in the availability of new anticonvulsant
drug require appropriate choice of animal models of epilepsy for the
identiﬁcation of anticonvulsant activity as well as new mechanism
of action [21].
Results  from the present study show that phytol may  be effec-
tive in blocking generalized tonic–clonic generalized seizures. On
the other hand, the genesis of the seizures originated due to
pilocarpine action involves the agonistic effect of this drug in
muscarinic receptors, which would reduce the inhibitory synap-
tic transmission to promote excitatory neurotransmission [30]. As
reported here, phytol confers protection against seizures induced
by pilocarpine. However, our results suggest that the mechanism
of phytol do not involve the GABAergic system, since antago-
nists of GABAergic receptors did not cause signiﬁcant differences.
Therefore, it is reasonable to suggest that the anticonvulsant
activity exerted by phytol may  not be associated to modulatory
effects on GABAergic system. On the other hand, ﬂumazenil was
unable to reverse their anticonvulsant effects, which indicates that
phytol may  exercise its mechanism of action directly and/or indi-
rectly through interaction with other systems neurotransmitters
(serotonin, noradrenergic and glutamatergic) that need to be inves-
tigated in future studies.
Although  phytol is modestly effective when compared to the
standard drugs used in our study (e.g. diazepam), the observed
effects appear to offer a potential advantage over most other
anticonvulsant compounds. For example, diazepam is especially
effective in preventing the generalized clonic–tonic convulsions
induced by pilocarpine.
Herein,  we  clearly showed that phytol decreased the frequency
of pilocarpine-induced seizures and increased the survival rate. In
our knowledge, these effects of phytol on mortality rate observed
during acute phases of pilocarpine-induced seizures have not been
reported before. Thus, these ﬁndings may  have important impli-
cations for understanding the mechanism of epilepsy to promote
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